Viemed Healthcare (NASDAQ:VMD) Insider William Frazier Sells 10,000 Shares of Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) insider William Frazier sold 10,000 shares of the company’s stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the transaction, the insider owned 73,214 shares of the company’s stock, valued at $858,068.08. This trade represents a 12.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Viemed Healthcare Trading Down 0.5%

Shares of VMD traded down $0.06 during trading hours on Friday, reaching $11.63. 882,599 shares of the company traded hands, compared to its average volume of 260,443. Viemed Healthcare, Inc. has a 12 month low of $5.93 and a 12 month high of $11.88. The company has a quick ratio of 1.10, a current ratio of 1.22 and a debt-to-equity ratio of 0.06. The company’s fifty day moving average price is $9.87 and its two-hundred day moving average price is $8.82. The company has a market capitalization of $445.89 million, a price-to-earnings ratio of 31.43 and a beta of 1.12.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.03). The company had revenue of $75.41 million during the quarter, compared to analysts’ expectations of $74.40 million. Viemed Healthcare had a return on equity of 10.52% and a net margin of 5.20%. Equities research analysts predict that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Viemed Healthcare

Several hedge funds have recently made changes to their positions in VMD. Segall Bryant & Hamill LLC bought a new position in Viemed Healthcare in the third quarter worth $1,965,000. Expect Equity LLC boosted its holdings in shares of Viemed Healthcare by 59.6% during the 4th quarter. Expect Equity LLC now owns 173,970 shares of the company’s stock valued at $1,293,000 after buying an additional 64,961 shares in the last quarter. Cove Street Capital LLC boosted its holdings in shares of Viemed Healthcare by 57.5% during the 3rd quarter. Cove Street Capital LLC now owns 219,848 shares of the company’s stock valued at $1,493,000 after buying an additional 80,227 shares in the last quarter. Ulland Investment Advisors LLC grew its position in shares of Viemed Healthcare by 142.4% in the 3rd quarter. Ulland Investment Advisors LLC now owns 73,095 shares of the company’s stock worth $496,000 after buying an additional 42,940 shares during the period. Finally, First Eagle Investment Management LLC lifted its position in Viemed Healthcare by 4.9% during the 3rd quarter. First Eagle Investment Management LLC now owns 477,844 shares of the company’s stock valued at $3,245,000 after acquiring an additional 22,500 shares during the period. 74.24% of the stock is currently owned by institutional investors.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.